Store
Sexually Transmitted Disease (STD) Testing Markets
Publication Date: April 26, 2019
Tags: Clinical Chemistry, Diagnostic Instruments, Immunoassay, Infectious Diseases, Molecular Diagnostics, Point-of-Care (POC) Testing
Pages: 160
SKU: 19-033
Sexually transmitted diseases (STDs) present a significant public health challenge, with approximately 550 million new cases worldwide each year, including over 35 million in the US alone. Kalorama Information’s latest report, Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics), offers an in-depth analysis of the global market for STD testing services and diagnostics from 2018 to 2023.
Report Highlights:
- Comprehensive Market Overview:
- Analysis of the global market for STD diagnostics, including:
- Chlamydia
- Gonorrhea
- Syphilis
- Human Papillomavirus (HPV)
- Human Immunodeficiency Viruses (HIV)
- Herpes Simplex Virus (HSV)
- Trichomonas Vaginalis (TV)
- Analysis of the global market for STD diagnostics, including:
- Geographic Analysis:
- Detailed examination of the STD diagnostics market by region:
- World Market for STD Diagnostics, 2018-2023 ($ billions)
- Regional Markets:
- North America (US, Canada, Mexico)
- Europe-Africa (UK, Spain, France, Italy, Germany, Africa)
- Asia-Pacific (Japan, China, India, Australia)
- South America (Argentina, Brazil, Chile)
- Rest of World (ROW)
- Detailed examination of the STD diagnostics market by region:
- Market Analysis by Disease and Region:
- Insights into the market for STD diagnostics by disease and region, covering trends and growth opportunities.
- Market Analysis by Testing Location and Laboratory Type:
- Breakdown of the market by testing location, including laboratory-based and point-of-care (POC) testing.
- Analysis by laboratory type (hospital labs, independent labs, physician office labs).
- Market Analysis by Testing Device:
- Examination of various diagnostic methods, including molecular platforms, lateral flow assays, flow cytometry, and ELISA diagnostics.
- Key Market Trends and Developments:
- Discussion of important market trends, such as antibiotic resistance, non-reportable STDs, emerging STDs, and advancements in STD testing technologies.
Data Points Included:
- Global and regional market sizes for STD diagnostics from 2018 to 2023
- Market segmentation by disease type and testing location
- Analysis of laboratory types and testing devices
Table: Global Sexually Transmitted Disease (STD) IVD Test Kit and Reagent Market, by Test Type & Condition, 2018-2026 (in millions $)
| Item – Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR |
| By Type of Test | ||||||||||
| Immunoassay | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Molecular | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Other | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| By Condition | ||||||||||
| Chlamydia | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| HPV | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Gonorrhea | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Herpes HSV-2 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Syphilis | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Other | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Global STD IVD Market | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| HIV | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
- Executive Summary
- Overview
- Growth in Cases of STDs
- Overview of STD Markets
- Table World Market for Sexually Transmitted Disease Test Services, 2018, 2021, 2023 ($billions)
- Table Global Sexually Transmitted Disease (STD) IVD Test Kit and Reagent Market by Test Type & Condition 2018 – 2026 ($millions)
- Methodology
- Introduction
- STDs Defined
- Economic Impact
- Modernizing Surveillance
- Key STDs
- Chlamydia
- Gonorrhea
- Syphilis
- Human Papillomavirus (HPV)
- Trichomonas Vaginalis
- Human Immunodeficiency Viruses (HIV)
- Herpes Simplex Virus (HSV)
- Incidence-Prevalence Overview
- US
- Table Rate of Reported Cases: Chlamydia among Men, per 100,000 Population, US, 2013-2016
- Table Rate of Reported Cases: Chlamydia among Women, per 100,000 Population, US, 2014-2017
- Table Rate of Reported Cases: Gonorrhea among Men, per 100,000 Population, US, 2014-2017
- Table Rate of Reported Cases: Gonorrhea among Women, per 100,000 Population, US, 2014-2017
- Table Rate of Reported Cases: Primary and Secondary Syphilis among Men, per 100,000 Population, US, 2014-2017
- Table Rate of Reported Cases: Primary and Secondary Syphilis among Women, per 100,000 Population, US, 2014-2017
- Table Percentage of US Adults with Genital HPV Infections, 2014
- Table Percentage of US Adults with High Risk Genital HPV Infections, 2014
- Table Prevalence of Infection by Trichomonas Vaginalis Infection in US, Percentage (Males, Females, Black Males, Black Females)
- Table HIV Diagnosis in US and Dependent Areas, Selected Populations, 2017
- Table Percentage Prevalence of HSV-1 and HSV-2 in Persons Aged 14 to 49 Years, US, 2016
- International
- Table Chlamydia Crude Notification Rate, EU-EEA Countries, 2017
- Table Full Achievement WHO Global STD Strategy 2016 to 2021
- Table Median Gonorrhea Rate among Adult Men, 64 Countries Reporting
- Table 2018 Baseline Estimates for Monitoring, the WHO Global STI Strategy, Syphilis and Congenital Syphilis
- Table Worldwide HPV-Related Statistics
- Table HIV/AIDS Global Data, 2017
- Table HSV Global Data
- STDs in Women and Infants
- Table STDs Affect Women Differently than Men
- US
- Market Trends and Analysis
- Incidence, Prevalence, and Cost of STDs
- Antibiotic Resistance
- Non-Reportable STDs
- Emerging STDs
- Newborn Syphilis Cases
- STDs in Women and Infants
- European vs. US Rates
- Highly Susceptible Groups
- Table Increased Rates of Syphilis, 2016 to 2017
- STD Test Services Issues
- Market Developments
- Novel Antibiotics Targets Gonorrhea
- Standard Treatment
- New App for Consumers
- Test Results in 30 Minutes
- At-Home HPV Testing
- Siemens Acquisition
- First Test to Aid in Diagnosis of Mycoplasma genitalium
- Automated RPR Syphilis Analyzer
- HSV Test Gets FDA Clearance
- FDA Clearance for cobas CT/NG for cobas Systems
- Funding POC Test Development
- HPV Test Approval
- Market Data
- Overview
- Growing Need for Testing
- Geographic Analysis
- Miniaturization and POC
- Table World Market for STD Test Services, 2018-2023 ($ billions)
- Table World Market for STD Test Services by Geography, 2018-2023 ($ billions)
- Table World Market for STD Test Services by Geography, 2018
- Table North American Market for STD Test Services by Geography, 2018-2023 ($ billions)
- Table North American Market for STD Test Services by Geography (US, Canada, Mexico)
- Table European-African Market for STD Test Services by Geography, 2018-2023 ($ billions)
- Table Asian-Pacific (APAC) Market for STD Test Services by Geography, 2018-2023 ($ billions)
- Table Latin American Market for STD Test Services by Geography, 2018-2023 ($ billions)
- Table Rest of World Market for STD Test Services, 2018-2023 ($ billions)
- Market Analysis by Disease and Region
- Table North American Market for STD Test Services, 2018-2023 ($ billions)
- Table European-African Market for STD Test Services, 2018-2023 ($ billions)
- Table Asia-Pacific (APAC) Market for STD Test Services, 2018-2023 ($ billions)
- Table Latin American Market for STD Test Services, 2018-2023 ($ billions)
- Table Rest of World Market for STD Test Services, 2018-2023 ($ billions)
- Market Analysis by Testing Location
- Table Worldwide Market for STD Test Services by Testing Location, 2018-2023 ($ billions)
- Table North American Market for STD Test Services by Testing Location, 2018-2023 ($ billions)
- Table European-African Market for STD Test Services by Testing Location, 2018-2023 ($ billions)
- Table Asia-Pacific (APAC) Market for STD Test Services by Testing Location, 2018-2023 ($ billions)
- Table Latin American Market for STD Test Services by Testing Location, 2018-2023 ($ billions)
- Table Rest of World Market for STD Test Services by Testing Location, 2018-2023 ($ billions)
- Table Worldwide Market for STD Test Services by Laboratory Type, 2018-2023 (%)
- Table North American Market for STD Test Services by Laboratory Type, 2018-2023 ($billions)
- Table European-African Market for STD Test Services by Laboratory Type, 2018-2023 ($ billions)
- Table Asia-Pacific (APAC) Market for STD Test Services by Laboratory Type, 2018-2023 ($ billions)
- Table Latin American Market for STD Test Services by Laboratory Type, 2018-2023 ($ billions)
- Table Rest of World Market for STD Test Services by Laboratory Type, 2018-2023 ($ billions)
- Market Analysis by Testing Device
- Table Selected Market-Available Hospital Molecular Diagnostic Platforms
- Table World Market for Molecular STD Test Services, 2018-2023 ($ billions)
- Table Worldwide Market for Molecular STD Test Services by Geography, 2018-2023 ($ billions)
- Table World Market for Lateral Flow Assay STD Test Services, 2018-2023 ($ billions)
- Table Worldwide Market for Lateral Flow Assay STD Test Services by Geography, 2018-2023 ($ billions)
- Table World Market for Flow Cytometry STD Test Services, 2018-2023 ($ billions)
- Table Worldwide Market for Flow Cytometry STD Test Services by Geography, 2018-2023 ($ billions)
- Table World Market for ELISA STD Test Services, 2018-2023 ($ billions)
- Table Worldwide Market for ELISA STD Test Services by Geography, 2018-2023 ($ billions)
- Table Global Sexually Transmitted Disease (STD) IVD Test Kit and Reagent Market by Test Type & Condition 2018 – 2026 ($millions)
- Miniaturization and POC
- Overview
- Competitive Landscape
- Alere-Abbott, Waltham, MA, www.alere.com
- Atlas Genetics Ltd. – binx Health, Trowbridge, UK, www.mybinxhealth.com
- Beckman Coulter-Danaher, Brea, CA, www.beckmancoulter.com
- Becton Dickinson, Franklin Lakes, NJ, www.bd.com
- Biomeme, Philadelphia, PA, www.biomeme.com
- bioMérieux, Marcy-l’Étoile, France, www.biomerieux.com
- Cepheid-Danaher, Sunnyvale, CA, www.cepheid.com
- GenePOC, Québec City, Canada, www.genepoc-diagnostics.com
- Hologic, Bedford, MA, www.hologic.com
- Meridian Bioscience, Cincinnati, OH, www.meridianbioscience.com
- OraSure Technologies, Bethlehem, PA, www.orasure.com
- QIAGEN, Venlo, the Netherlands, www.qiagen.com
- QuantuMDx, Newcastle upon Tyne, UK, www.quantumdx.com
- Quidel, San Diego, CA, www.quidel.com
- Roche Diagnostics, Indianapolis, IN, www.roche.com
- Seegene, Seoul, Korea, www.seegene.com
- Sekisui Diagnostics, Lexington, MA, www.sekisuidiagnostics.com
- Siemens Healthineers, Erlangen, Germany, www.siemenshealthineers. com
- Trinity Biotech Plc, Bray, County Wicklow, Ireland, www.trinitybiotech.com
- uBiome, San Francisco, CA, www.ubiome.com
Related products
Remote Patient Monitoring and Telehealth Markets, 13th Edition
November 27, 2023
Telehealth and remote patient monitoring have revolutionized healthcare by improving health conditions and preventing complications. The pandemic accelerated the adoption of telemedicine, boosting confidence in virtual patient assessments and technological monitoring. Remote Patient Monitoring and Telehealth Markets, 13th Edition by Kalorama Information explores these transformations and more, providing a comprehensive analysis of the market.
…
$5,000.00 – $7,500.00
IVD Market Trends Report, March 2023
March 17, 2023
Diagnostic testing remains a cornerstone in healthcare, aiding physicians in diagnosis and providing crucial information for treatments like precision medicine. As we navigate the aftermath of the COVID-19 pandemic, the IVD market is evolving, driven by new products, shifts in global health spending, regulatory updates, and changing disease trends. Despite these shifts, the IVD market…
$3,000.00 – $4,500.00
30-Country In Vitro Diagnostic (IVD) Market Atlas [October 2023 Update]
October 27, 2023
The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.
Key…
$5,000.00 – $7,500.00
